Viemed Healthcare (VMD) Depreciation & Amortization (CF) (2018 - 2026)
Viemed Healthcare (VMD) posted Depreciation & Amortization (CF) of $7.6 million for Q1 2026, up 0.67% on a QoQ basis from $7.6 million in Q4 2025, and up 15.24% year-over-year from $6.6 million in Q1 2025.
Viemed Healthcare (VMD) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Viemed Healthcare's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $7.6 million for Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 15.24% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.6 million (up 15.27% YoY) and the FY2025 annual result came in at $28.6 million, up 12.79% from the prior year.
- Depreciation & Amortization (CF) was $7.6 million for Q1 2026 at Viemed Healthcare, up from $7.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $7.6 million in Q1 2026 and bottomed at $3.4 million in Q1 2022.
- A 5-year average of $5.8 million and a median of $6.3 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) jumped 44.99% — and 2025, when it increased 5.22%.
- Viemed Healthcare's Depreciation & Amortization (CF) stood at $4.4 million in 2022, then surged by 35.35% to $5.9 million in 2023, then increased by 7.55% to $6.4 million in 2024, then gained by 18.91% to $7.6 million in 2025, then climbed by 0.67% to $7.6 million in 2026.
- Business Quant data shows VMD's Depreciation & Amortization (CF) at $7.6 million in Q1 2026, $7.6 million in Q4 2025, and $7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn | 7.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.62 Mn |
| Mar 31, 2026 | 7.62 Mn |
| Dec 31, 2025 | 7.57 Mn |
| Dec 31, 2025 | 7.57 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 6.89 Mn |
| Jun 30, 2025 | 6.89 Mn |
| Mar 31, 2025 | 6.61 Mn |
| Mar 31, 2025 | 6.61 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Sep 30, 2024 | 6.41 Mn |
| Sep 30, 2024 | 6.41 Mn |
| Jun 30, 2024 | 6.31 Mn |
| Jun 30, 2024 | 6.31 Mn |
| Mar 31, 2024 | 6.29 Mn |
| Mar 31, 2024 | 6.29 Mn |
| Dec 31, 2023 | 5.92 Mn |
| Dec 31, 2023 | 5.92 Mn |